BREAKING NEWS

BeyondSpring announces submission of New Drug Application (NDA) to U.S. FDA and China NMPA for Plinabulin and G-CSF combination for the prevention of chemotherapy-induced neutropenia (CIN).
Read more

Events & presentations

Events & presentations

Discover our most recent and upcoming events, as well as download informative presentations—all right here.

Upcoming events

11.16.2020

BeyondSpring PROTECTIVE-2 Phase 3 Trial Topline Results Update

Past Events

Presentations